EP2024497A4 - Protéines liga et ligb (domaines de type ig leptospire (lig)) destinées à la vaccination et à l'établissement d'un diagnostic - Google Patents

Protéines liga et ligb (domaines de type ig leptospire (lig)) destinées à la vaccination et à l'établissement d'un diagnostic

Info

Publication number
EP2024497A4
EP2024497A4 EP06828120A EP06828120A EP2024497A4 EP 2024497 A4 EP2024497 A4 EP 2024497A4 EP 06828120 A EP06828120 A EP 06828120A EP 06828120 A EP06828120 A EP 06828120A EP 2024497 A4 EP2024497 A4 EP 2024497A4
Authority
EP
European Patent Office
Prior art keywords
ligb
leptospiral
liga
lig
vaccination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06828120A
Other languages
German (de)
English (en)
Other versions
EP2024497A2 (fr
Inventor
Marco Alberto Medeiros
Reis Mitemayer Galvao Dos
Silva Everton Fagonde Da
Alan John Alexander Mcbride
Julio Henrique Rosa Croda
Joao Gabriel Rosa Ramos
Odir Antonio Dellagostin
Flavia Weykamp Cruz Mcbride
Albert Icksang Ko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundacao Oswaldo Cruz
Cornell Research Foundation Inc
Original Assignee
Fundacao Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao Oswaldo Cruz filed Critical Fundacao Oswaldo Cruz
Publication of EP2024497A2 publication Critical patent/EP2024497A2/fr
Publication of EP2024497A4 publication Critical patent/EP2024497A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP06828120A 2005-12-19 2006-12-19 Protéines liga et ligb (domaines de type ig leptospire (lig)) destinées à la vaccination et à l'établissement d'un diagnostic Withdrawn EP2024497A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0505529-6A BRPI0505529A (pt) 2005-12-19 2005-12-19 proteìnas liga e ligb (leptospiral ig-like(lig) domains) para vacinação e diagnóstico
PCT/BR2006/000283 WO2007070996A2 (fr) 2005-12-19 2006-12-19 Proteines liga et ligb (domaines de type ig leptospire (lig)) destinees a la vaccination et a l'etablissement d'un diagnostic

Publications (2)

Publication Number Publication Date
EP2024497A2 EP2024497A2 (fr) 2009-02-18
EP2024497A4 true EP2024497A4 (fr) 2010-03-17

Family

ID=38189000

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06828120A Withdrawn EP2024497A4 (fr) 2005-12-19 2006-12-19 Protéines liga et ligb (domaines de type ig leptospire (lig)) destinées à la vaccination et à l'établissement d'un diagnostic

Country Status (4)

Country Link
EP (1) EP2024497A4 (fr)
BR (1) BRPI0505529A (fr)
CA (1) CA2634214A1 (fr)
WO (1) WO2007070996A2 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60222812T2 (de) * 2002-05-17 2008-08-28 Fundação Oswaldo Cruz (Fiocruz) In leptospira-spezies vorhandene proteine mit repetitiven bakterien-ig-ähnlichen (big-) domänen
EP2447278B1 (fr) * 2002-10-10 2015-04-08 Cornell Research Foundation, Inc. Nouvelles protéines immunogènes de Leptospira

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "UNIPROT:O05734", 1 July 1997 (1997-07-01), XP055325287, Retrieved from the Internet <URL:http://ibis.internal.epo.org/exam/dbfetch.jsp?id=UNIPROT:O05734> [retrieved on 20161201] *
DATABASE EMBL [online] 13 February 2002 (2002-02-13), "Sequence 3 from Patent WO0191536.", XP002565996, retrieved from EBI accession no. EMBL:AX358376 Database accession no. AX358376 *
DATABASE EMBL [online] 25 March 2003 (2003-03-25), "Leptospira interrogans serovar copenhageni putative immunoglobulin-like protein A (ligA) gene, complete cds.", retrieved from EBI accession no. EMBL:AY221109 Database accession no. AY221109 *
DATABASE Geneseq [online] 23 March 2001 (2001-03-23), "Yeast NORF gene SAGE tag oligonucleotide SEQ ID NO:870.", XP002565995, retrieved from EBI accession no. GSN:AAF34131 Database accession no. AAF34131 *
PALANIAPPAN R U M ET AL: "Cloning and molecular characterization of an immunogenic LigA protein of Leptospira interrogans", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 70, no. 11, 1 November 2002 (2002-11-01), pages 5924 - 5930, XP002348167, ISSN: 0019-9567, DOI: 10.1128/IAI.70.11.5924-5930.2002 *
See also references of WO2007070996A2 *

Also Published As

Publication number Publication date
CA2634214A1 (fr) 2007-06-28
WO2007070996A3 (fr) 2007-09-20
BRPI0505529A (pt) 2007-09-25
EP2024497A2 (fr) 2009-02-18
WO2007070996A2 (fr) 2007-06-28

Similar Documents

Publication Publication Date Title
IL263755A (en) Antibodies that bind human protein tyrosine phosphate in the cell and their uses
CY2016023I2 (el) Πρωτεϊνες συνδεσης αντιγονου προς προπρωτεϊνη κονβερτασης σουμπτιλισινης κεχιν τυπου 9 (pcsk9)
ZA201002160B (en) Human gm-csf antigen binding proteins
EP1889908A4 (fr) Protéine fusionnée possédant un anticorps anti-cd14
EP1951280A4 (fr) Peptides de techniques diagnostiques et therapeutiques de maladie coeliaque
DK1877090T3 (da) Trimert ox40-immunoglobulin-fusionsprotein og fremgangsmåder til anvendelse heraf
ZA201001541B (en) Human c-fms antigen binding proteins
EP1877437A4 (fr) Protéines chimériques possédant des domaines de liaison à phosphatidylsérine
WO2007084264A3 (fr) Procedes d’imagerie myocardique
BRPI0813016A2 (pt) &#34;proteínas de ligação de antígeno ao receptor de il-18&#34;
EP1991565A4 (fr) Protéines chimériques du toxoïde de shiga
EP1957520A4 (fr) Antigene ospc chimere polyvalent vaccinogene et diagnostique
EP1989552A4 (fr) Marqueurs protéiques destinés à diagnostiquer un cancer de l&#39;estomac et nécessaire de diagnostic les utilisant
EP2099904A4 (fr) Procédé permettant de générer de nouvelles protéines stabilisées
DE602006013109D1 (de) Markerprotein zur verwendung bei der diagnose von bauchspeicheldrüsenkrebs
EP1913395A4 (fr) Anticorps et méthodes permettant de prévoir la formation de caries dentaires
EP1888111A4 (fr) Modulation de l&#39;activité de la protéine de transfert de cholestérylester (cetp)
EP1773385A4 (fr) Immunisation transcutanee utilisant des proteines de fusion lt-sta
EP1999261A4 (fr) Utilisation de la fusion de la proteine s permettant une solubilisation proteique
EP2024497A4 (fr) Protéines liga et ligb (domaines de type ig leptospire (lig)) destinées à la vaccination et à l&#39;établissement d&#39;un diagnostic
HK1098165A1 (en) Long acting human erythropoietin fusion protein and method for preparing and purifying the same
GB0511846D0 (en) Protein crystal
ZA200807978B (en) Antibodies that bind human protein tyrosine phosphatase beta (HPTPBETA) and uses thereof
EP2082229A4 (fr) Compositions et procédés pour effectuer le test de troncation des protéines dans les tissus pour diagnostiquer une maladie
IL185932A0 (en) Compositions of hsp60 peptides and viral antigers for vaccination and diagnosis

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081107

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: DOS REIS, MITEMAYER, GALVAO

Inventor name: MCBRIDE, ALAN, JOHN, ALEXANDER

Inventor name: RAMOS, JOAO, GABRIEL, ROSA

Inventor name: DA SILVA, EVERTON, FAGONDE

Inventor name: KO, ALBERT, ICKSANG

Inventor name: MCBRIDE, FLAVIA, WEYKAMP, CRUZ

Inventor name: DELLAGOSTIN, ODIR, ANTONIO

Inventor name: CRODA, JULIO, HENRIQUE, ROSA

Inventor name: MEDEIROS, MARCO, ALBERTO

A4 Supplementary search report drawn up and despatched

Effective date: 20100212

17Q First examination report despatched

Effective date: 20100416

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: FUNDACAO OSWALDO CRUZ - FIOCRUZ

Owner name: CORNELL RESEARCH FOUNDATION, INC.

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20180322

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180802